ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,353Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 464

$400K Total Retail Price of All Prescriptions

Rank: 20 out of 464

386 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

6% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 6,182 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 386 310 1 3
ATENOLOL 263 257 2 9
LISINOPRIL 252 219 3 1
OMEPRAZOLE 243 209 4 18
FUROSEMIDE 238 211 5 5
AMLODIPINE BESYLATE 229 196 6 6
METOPROLOL TARTRATE 216 189 7 4
LEVOTHYROXINE SODIUM 181 164 8 19
ZOLPIDEM TARTRATE 164 145 9 37
HYDROCHLOROTHIAZIDE 159 147 10 10
ATORVASTATIN CALCIUM 154 148 11 7
TRAMADOL HCL 116 92 12 55
OXYCODONE-ACETAMINOPHEN 109 50 S2 13 57
HYDROCODONE-ACETAMINOPHEN 103 82 S3 14 46
PREDNISONE 97 87 15 60
WARFARIN SODIUM 94 81 16 8
RANITIDINE HCL 93 82 17 48
SERTRALINE HCL 92 82 18 50
METFORMIN HCL 92 68 18 22
AZITHROMYCIN 87 65 20 68
TAMSULOSIN HCL 86 78 21 47
METOPROLOL SUCCINATE 77 64 22 2
FLUOXETINE HCL 73 69 23 101
DIGOXIN 73 62 23 14
PRAVASTATIN SODIUM 70 56 25 15
GABAPENTIN 70 49 25 41
PROAIR HFA 66 37 27 52
OXYCODONE HCL 62 22 S2 28 87
TRIAMTERENE-HCTZ 61 52 29 51
AMOXICILLIN 60 43 30 91
TRAZODONE HCL 60 55 30 45
CIPROFLOXACIN HCL 57 53 32 98
CLOPIDOGREL 56 54 33 17
MECLIZINE HCL 55 28 34 166
QUINAPRIL HCL 54 54 35 54
LORAZEPAM 50 50 36 92
ADVAIR DISKUS 50 45 36 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.